Mayo Clinic Q and A: Mitral valve repair with minimally invasive heart surgery
DEAR MAYO CLINIC: Is minimally invasive heart surgery to repair a mitral valve a safer option than open-heart surgery? Is it common for a surgeon to have to switch to an open-heart procedure after starting the surgery? ANSWER: Both minimally invasive heart surgery and traditional surgery that involves opening the chest bone -- a procedure [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 28, 2019 Category: Databases & Libraries Source Type: news
Medtech in a Minute: LivaNova Nixes TMVR, FDA Tackles EtO, and More
FDA Wants Medtech to Cut Back on EtO Use
FDA is encouraging manufacturers to reduce the amount of paper included in sterile device packaging in order to reduce the amount of ethylene oxide (EtO) required for effective sterilization. A new voluntary master file program also aims to speed up approval of sterilization site relocations and the implementation of methods that reduce the amount of EtO needed to sterilize FDA-approved medical devices.
Â
LivaNova Says Sayonara to TMVR
LivaNova is scrapping its Caisson transcatheter mitral valve replacement program because of continued...
Source: MDDI - November 27, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news
Lower Operating Thresholds for Chronic Severe AR? Lower Operating Thresholds for Chronic Severe AR?
Should current guidelines be revised to include earlier aortic valve surgery for asymptomatic patients with severe aortic regurgitation and a preserved LVEF?Circulation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 26, 2019 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
LivaNova Stops Caisson TMVR Program
LivaNova is scrapping its Caisson transcatheter mitral valve replacement (TMVR) program because of declines its heart valve business has seen over the last five years. Plans now call for the London-based company to enter into a restructuring plan for its heart valve business, which brought in $130 million in revenue in 2018.
Under the restructuring plan, it is expected that about 150 employees could be potentially impacted in the three sites of Saluggia, Vancouver, and Minneapolis. LivaNova’s Saluggia, Italy facility will now become dedicated to R&D and production of mechanical heart valves, rings, ac...
Source: MDDI - November 21, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news
RECOVERY: Early Surgery Best in Severe Asymptomatic AS? RECOVERY: Early Surgery Best in Severe Asymptomatic AS?
In asymptomatic patients with very severe aortic stenosis, early aortic valve replacement surgery was associated with lower mortality than a more conservative course.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - November 19, 2019 Category: Intensive Care Tags: Cardiology News Source Type: news
Cardiac rehab after heart valve surgery tied to better outcomes
(Reuters Health) - Cardiac rehab, known to be helpful after heart attacks, may also aid recovery from heart valve surgery, a study suggests. (Source: Reuters: Health)
Source: Reuters: Health - October 31, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
Rate of Surgical Bailout Low for TAVR
THURSDAY, Oct. 31, 2019 -- The need for surgical bailout in patients undergoing transcatheter aortic valve replacement (TAVR) is low, according to a study recently published in JACC: Cardiovascular Interventions.
Andres M. Pineda, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 31, 2019 Category: Pharmaceuticals Source Type: news
Boston Sci Gives Update on the Measured Launch of Lotus Edge
Boston Scientific’s Lotus Edge might be one of the biggest and most significant FDA approvals of 2019. However, Boston Scientific has been very measured with launch plans for the transcatheter aortic valve replacement technology.
During a recent earnings call, the Marlborough, MA-based company gave an update on the rollout of Lotus Edge to analysts and investors.
“The Lotus Edge launch is going extremely well and we’re building momentum in both the U.S. and Europe,†said Michael Mahoney, chairman and CEO of Boston Scientific, according to a Seeking Alp...
Source: MDDI - October 28, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Cardiovascular Source Type: news
4 core applications of cardiovascular 3D printing
How are clinicians integrating 3D printing technology into adult cardiovascular...Read more on AuntMinnie.comRelated Reading:
3D-bioprinted model mimics real human heart properties
4D flow MRI, 3D printing improve congenital heart surgery
3D printing technique improves heart valve sizing
3D printing bolsters care for congenital heart disease
Flexible 3D-printed heart replicates size, texture (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 28, 2019 Category: Radiology Source Type: news
3Q19 Earnings Show Edwards Continues to Have Solid TAVR Story
Edwards Lifesciences made tremendous gains in 3Q19 by toppling consensus forecast and significantly raising revenue. As a result, shares of Edwards jumped by nearly 6%.
The Irvine, CA-based company, often called a pioneer in the transcatheter aortic valve replacement (TAVR) market, improved third quarter net sales 20.7% year-over-year to $1.09 billion. Diluted earnings per share for the quarter were $1.30, while adjusted earnings per share grew 32% to $1.41.
For 2019, the company now expects total sales around the top of its previous $4 billion to $4.3 billion range. Additionally, the company raised its full-year 2019 adju...
Source: MDDI - October 24, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Cardiovascular Source Type: news
AI is a Big Part of Cleveland Clinic ’s 2019 MIS
CLEVELAND – Two words dominated much of the program agenda for Cleveland Clinic’s 2019 Medical Innovation Summit (MIS) on Tuesday – Artificial Intelligence.
From a keynote address from Craig Mundie, Senior Advisor to the CEO, and former Chief Research and Strategy Officer, Microsoft to a session discussing companies with non-traditional approaches to healthcare, the topic of AI was discussed.
But is AI just the latest fad in healthcare? Is it fully-defined? And are there real-world examples to look to, to see AI in action? Richard Zane, MD CIO of University of Colorado ...
Source: MDDI - October 23, 2019 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Source Type: news
Tallest man in US breaks down in tears as he reveals that he'll die without heart surgery
Igor Vovkovinskiy, 37, who is 7 feet and 8.33 inches tall, posted a video in which he revealed that he needs heart surgery to fix a valve, but doesn't know if he will survive the operation. (Source: the Mail online | Health)
Source: the Mail online | Health - October 16, 2019 Category: Consumer Health News Source Type: news
Admedus Turns Attention to TAVR Program
Change is in the air for Admedus. The Brisbane, Australia-based company is selling off its CardioCel and VascuCel businesses to LeMaitre Vascular. The deal would give Admedus the space to focus on its transcatheter aortic valve replacement products.
Under the agreement terms, Admedus receives $A22.8 million upfront followed by deferred payments of $A1 million each at 12 months and at 36 months. Additionally, the company could receive up to $A11.4 million in earn-out payments.
Admedus said it retains manufacturing rights for up to three years and will continue manufacturing CardioCel and VascuCel at its Malaga facility in W...
Source: MDDI - October 15, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Cardiovascular Source Type: news
Penn Medicine, Mercy Health to establish heart surgery program in Delaware County
Mercy Catholic Medical Center and Penn Medicine are teaming up to establish a cardiovascular surgery program at the Mercy Fitzgerald Campus in Darby.
The partnership — preceding by a clinical affiliation between the health care providers forged last year — will include expanding patient access to a wide range of surgical and non-surgical procedures, such as transcatheter aortic valve replacement (TAVR) and robotic cardiac surgery. TAVR is a minimally invasive procedure to treat aortic valve… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 14, 2019 Category: Pharmaceuticals Authors: John George Source Type: news
A Blood Filter Fights Deadly Inflammatory Response
A new blood filtration technology may prove to be life-saving for patients whose normally healthy inflammatory response to injury or illness has gone into overdrive, resulting in fatally high levels of cytokines in their blood. In an interview with MD+DI, Dr. Phillip Chan, MD, PhD, CEO of CytoSorbents Corp., explained that inflammation, and the production of substances called cytokines that drive inflammation, are the body’s natural response to heal injury or infection. But sometimes, the inflammatory response is so severe in such conditions as sepsis and infection, burn injuries, trauma, pancreatitis, li...
Source: MDDI - October 9, 2019 Category: Medical Devices Authors: Susan Shepard Tags: Cardiovascular Source Type: news
